{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:34:06Z","timestamp":1778751246244,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.aca.2020.04.069","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T16:21:33Z","timestamp":1588263693000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Selective and sensitive detection of chronic myeloid leukemia using fluorogenic DNAzyme probes"],"prefix":"10.1016","volume":"1123","author":[{"given":"Xiaofang","family":"Geng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-413X","authenticated-orcid":false,"given":"Zhifa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2020.04.069_bib1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.aca.2020.04.069_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2016.11.005","article-title":"Preclinical approaches in chronic myeloid leukemia: from cells to systems","volume":"47","author":"Clarke","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.aca.2020.04.069_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","article-title":"Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia","volume":"306","author":"Bartram","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.aca.2020.04.069_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A\u00a0cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"de Klein","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.aca.2020.04.069_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.aca.2020.04.069_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0805-1","article-title":"Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia","volume":"17","author":"Massimino","year":"2018","journal-title":"Mol cancer"},{"key":"10.1016\/j.aca.2020.04.069_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrclinonc.2016.139","article-title":"Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?","volume":"14","author":"Rosti","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.aca.2020.04.069_bib8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3324\/haematol.2017.182022","article-title":"Present results and future perspectives in optimizing chronic myeloid leukemia therapy","volume":"103","author":"Carella","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.aca.2020.04.069_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.aca.2020.04.069_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.critrevonc.2015.08.020","article-title":"Chronic myeloid leukemia: relevance of cytogenetic and molecular assays","volume":"97","author":"Bennour","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.aca.2020.04.069_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2006.03.004","article-title":"Conventional cytogenetics and FISH in the detection of BCR\/ABL fusion in chronic myeloid leukemia (CML)","volume":"81","author":"Mark","year":"2006","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.aca.2020.04.069_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.2237408","article-title":"Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization","volume":"250","author":"Tkachuk","year":"1990","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.aca.2020.04.069_bib13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ajh.23238","article-title":"Early landmark analysis of imatinib treatment in CML chronic phase: less than 10% BCR-ABL by FISH at 3 months associated with improved long-term clinical outcome","volume":"87","author":"Ohm","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.aca.2020.04.069_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0140-6736(90)91102-G","article-title":"False-positive results with PCR to detect leukaemia-specific transcript","volume":"335","author":"Hughes","year":"1990","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.aca.2020.04.069_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bjh.14557","article-title":"Measurement of BCR-ABL1 by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme","volume":"177","author":"Scott","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.aca.2020.04.069_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1373\/clinchem.2016.262824","article-title":"RT-qPCR and RT-digital PCR: a comparison of different platforms for the evaluation of residual disease in chronic myeloid leukemia","volume":"63","author":"Alikian","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.aca.2020.04.069_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/1074-5521(94)90014-0","article-title":"A\u00a0DNA enzyme that cleaves RNA","volume":"1","author":"Breaker","year":"1994","journal-title":"Chem. Biol."},{"key":"10.1016\/j.aca.2020.04.069_bib18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2353\/ajpath.2007.070120","article-title":"Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies","volume":"171","author":"Bhindi","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.aca.2020.04.069_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/14712598.2015.1025048","article-title":"DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes","volume":"15","author":"Fokina","year":"2015","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.aca.2020.04.069_bib20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/acs.accounts.7b00262","article-title":"Discovery and biosensing applications of diverse RNA-cleaving DNAzymes","volume":"50","author":"Liu","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.aca.2020.04.069_bib21","article-title":"Lighting up RNA-cleaving DNAzymes for biosensing","volume":"2012","author":"Tram","year":"2012","journal-title":"J.\u00a0Nucleic Acids"},{"key":"10.1016\/j.aca.2020.04.069_bib22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/17425247.2017.1266326","article-title":"Delivery of therapeutic RNA-cleaving oligodeoxyribonucleotides (deoxyribozymes): from cell culture studies to clinical trials","volume":"14","author":"Fokina","year":"2017","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.aca.2020.04.069_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/ja0281232","article-title":"An efficient RNA-cleaving DNA enzyme that synchronizes catalysis with fluorescence signaling","volume":"125","author":"Mei","year":"2003","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.aca.2020.04.069_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-61779-545-9_25","article-title":"Developing fluorogenic RNA-cleaving DNAzymes for biosensing applications","volume":"848","author":"Ali","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.aca.2020.04.069_bib25","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1002\/anie.201100477","article-title":"Fluorogenic DNAzyme probes as bacterial indicators","volume":"50","author":"Ali","year":"2011","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.aca.2020.04.069_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/biom3030563","article-title":"A\u00a0sensitive DNA enzyme-based fluorescent assay for bacterial detection","volume":"3","author":"Aguirre","year":"2013","journal-title":"Biomolecules"},{"key":"10.1016\/j.aca.2020.04.069_bib27","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/anie.201510125","article-title":"A\u00a0catalytic DNA activated by a specific strain of bacterial pathogen","volume":"55","author":"Shen","year":"2016","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.aca.2020.04.069_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1021\/ac5031557","article-title":"Highly specific recognition of breast tumors by an RNA-cleaving fluorogenic DNAzyme probe","volume":"87","author":"He","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2020.04.069_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.aca.2020.04.069_bib30","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/s17030650","article-title":"The optimization and characterization of an RNA-cleaving fluorogenic DNAzyme probe for MDA-MB-231 cell detection","volume":"17","author":"Xue","year":"2017","journal-title":"Sensors"}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267020304967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267020304967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:21:06Z","timestamp":1757704866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267020304967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":30,"alternative-id":["S0003267020304967"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2020.04.069","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective and sensitive detection of chronic myeloid leukemia using fluorogenic DNAzyme probes","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2020.04.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}